 |
| Kate Allatt A Rocky Stroke Recovery |
Dame Professor Nancy Rothwell Vice President at Manchester University, always replies to emails immediately, like me!She hates seeing her inbox full and she also likes to do things here and now, again I wonder who that reminds me of?
She’s a list person and juggles many roles.
As an academic she hates being told what to do too. Ooh remind you of anyone? (Although, I’d describe myself as bloody-minded!)
Above all she is a rule breaker and I like that!
On a more serious note, we have much in common on stroke.
Here is a quote from her on BBC radio 4 recently.
‘Big breakthroughs come often from intuitive or creative leaps rather than logical progression.’
HERE, HERE!
Hear her full BBC radio 4 interview here: BBC Radio 4 The Life Scientific.
She is heavily involved with the clinical trial of the IL-1 inhibitor in stroke. A drug which is designed to prevent the onset of the second stage of stroke damage, after the initial stroke brain damage.
The development has only taken 20 years because there is no money behind stroke research.
Over the years 100s of stroke trials have failed, so there are no big companies left in stroke research.
How ridiculous, when sadly someone in the world will have a stroke every 6 seconds, according to The World Stroke Organisation.
I absolutely have to thank Gillian Moreton (not Melanie!) who alerted me to Dame Professor Rothwell on my Fighting Strokes Facebook page.
I can’t wait for our telephone meeting scheduled this Thursday! Could this telephone meeting be an important breakthrough for Fighting Strokes?
Biography of Dame Professor Nancy Rothwell
Nancy Rothwell obtained a first class degree in Physiology in 1976, a PhD in 1978 and a DSc in 1987 from the University of London. Her early research identified mechanisms of energy balance regulation, obesity and cachexia. In 1984 she was awarded a Royal Society Research Fellowship and relocated to Manchester in 1987. Nancy was awarded a Chair in physiology in 1994, then a prestigious Medical Research Council Research Chair in 1998. Her current research focuses on the role of inflammation in brain disease and has identified the role of the cytokine interleukin-1 (IL-1) in diverse forms of brain injury. Her recent studies have begun to elucidate the mechanisms regulating IL-1 release and its action, and her group has conducted the first early clinical trial of an IL-1 inhibitor in stroke. She has previously served as president of the British Neuroscience Association, a council member of MRC, BBSRC and Cancer Research UK.
Nancy currently oversees a research group of about 20 scientists, with significant external funding, and is President & Vice-Chancellor at The University of Manchester. She has recently been a member of the Royal Society Council, Vice President of the Royal Society, Chair of the Royal Society Education Committee, and is currently President of the Society of Biology and a non-executive director of AstraZeneca. In 2003 she won the prestigious Pfizer Research Prize, in 2004 was elected a Fellow of the Royal Society and in 2005 was honoured with a DBE. She was recently appointed as Deputy Lieutenant for Greater Manchester, a member of the Prime Minister’s Council for Science and Technology and the Greater Manchester Local Enterprise Partnership.
Nancy takes a strong and active interest in public communication of science and regularly gives talks to schools and the public and contributes to television, radio and press, particularly on sensitive issues in science. In 1998 she delivered the Royal Institution Christmas Lectures, televised by the BBC.
See the original article:
in
No comments:
Post a Comment